NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s traded shares stood at 1.0 million during the last session, with the company’s beta value hitting 1.23. At the close of trading, the stock’s price was $1.57, to imply an increase of 10.56% or $0.15 in intraday trading. The NRXP share’s 52-week high remains $7.33, putting it -366.88% down since that peak but still an impressive 29.94% since price per share fell to its 52-week low of $1.10. The company has a valuation of $21.00M, with an average of 0.52 million shares in intraday trading volume over the past 10 days and average of 193.72K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for NRX Pharmaceuticals Inc (NRXP), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give NRXP a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
NRX Pharmaceuticals Inc (NASDAQ:NRXP) trade information
After registering a 10.56% upside in the last session, NRX Pharmaceuticals Inc (NRXP) has traded red over the past five days. The 5-day price performance for the stock is 3.05%, and 34.13% over 30 days. With these gigs, the year-to-date price performance is -63.26%. Short interest in NRX Pharmaceuticals Inc (NASDAQ:NRXP) saw shorts transact 0.68 million shares and set a 4.8 days time to cover.
The extremes give us $2 and $2 for target low and target high price respectively. As such, NRXP has been trading -27.39% off suggested target high and -27.39% from its likely low.
NRX Pharmaceuticals Inc (NRXP) estimates and forecasts
Looking at statistics comparing NRX Pharmaceuticals Inc share performance against respective industry, we note that the company has outperformed competitors. NRX Pharmaceuticals Inc (NRXP) shares are -29.88% down over the last 6 months, with its year-to-date growth rate higher than industry average at 52.70% against 16.40%.
NRXP Dividends
NRX Pharmaceuticals Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
NRX Pharmaceuticals Inc (NASDAQ:NRXP)’s Major holders
NRX Pharmaceuticals Inc insiders hold 23.56% of total outstanding shares, with institutional holders owning 6.05% of the shares at 7.92% float percentage. In total, 6.05% institutions holds shares in the company.
